Bausch Health Companies market cap BHC
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Nov 2, 2026
- $3B
- Highest close in our data
- $88.3B
- Jul 2015
Bausch Health Companies is worth $3B at the close on Nov 2, 2026, at $8.02 a share.
That is up 22% over the last year and down 70% over five years.
Its highest close in our data was $88.3B in Jul 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3B | $1.7B | $3.1B | +13% |
| 2025 | $2.7B | $1.6B | $3.1B | −5% |
| 2024 | $2.8B | $2B | $3.9B | −4% |
| 2023 | $2.9B | $2.1B | $3.5B | +29% |
| 2022 | $2.3B | $1.7B | $9.7B | −77% |
| 2021 | $9.9B | $8.2B | $11.9B | +34% |
| 2020 | $7.4B | $4.7B | $10.7B | −29% |
| 2019 | $10.5B | $6.7B | $10.9B | +59% |
| 2018 | $6.6B | $5.2B | $9.5B | −9% |
| 2017 | $7.2B | $3B | $7.5B | +43% |
| 2016 | $5B | $4.9B | $33.1B | −86% |
| 2015 | $34.9B | $25.9B | $88.3B | −27% |
| 2014 | $47.5B | $36.6B | $49B | +25% |
| 2013 | $37.9B | $18.5B | $37.9B | +111% |
| 2012 | $17.9B | $13.7B | $18.5B | +25% |
| 2011 | $14.4B | $10.5B | $16.8B | +69% |
| 2010 | $8.5B | $3.6B | $9B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Bausch Health Companies' size, closest first, today.
| Company | Market cap |
|---|---|
| BHCBausch Health Companies | $3B |
| NRIXNurix Therapeutics | $2.8B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.7B |
| PBHPrestige Consumer Healthcare | $2.4B |
| ARQTArcutis Biotherapeutics | $3.9B |
| HRMYHarmony Biosciences | $2.2B |
| INDVIndivior Pharmaceuticals | $4.3B |
| ANIPANI Pharmaceuticals | $1.6B |
| PAHCPhibro Animal Health | $1.6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| Peer median | $3.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Bausch Health Companies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.